Related Experiment Videos

[Effect on endothelin and cytokines on the pathogenesis of coronary heart disease]

Y Guan1, M Zhang, H Yuan

  • 1Department of Cardiology, Third Affiliated Hospital, Hunan Medical University, Changsha.

Hunan Yi Ke Da Xue Xue Bao = Hunan Yike Daxue Xuebao = Bulletin of Hunan Medical University
|May 12, 2000
PubMed

Insights

Plasma endothelin (ET) and tumor necrosis factor (TNF) levels are elevated in coronary heart disease (CHD) patients, particularly those with acute myocardial infarction (AMI). Interleukin-6 (IL-6) is also significantly higher in AMI patients, suggesting a role for these markers in CHD pathogenesis.

Area of Science:

  • Biochemistry
  • Immunology
  • Cardiology

Context:

  • Coronary heart disease (CHD) is a leading cause of mortality worldwide.
  • Biomarkers for CHD pathogenesis are crucial for early diagnosis and treatment.
  • Endothelin (ET), tumor necrosis factor (TNF), and interleukin-6 (IL-6) are implicated in cardiovascular inflammation and disease.

Purpose:

  • To investigate the plasma levels of endothelin (ET) and serum levels of tumor necrosis factor (TNF) and interleukin-6 (IL-6) in patients with coronary heart disease (CHD).
  • To compare these levels between patients with CHD, including acute myocardial infarction (AMI), and healthy controls.
  • To elucidate the potential role of ET and cytokines in the pathogenesis of CHD.

Summary:

  • Radioimmunoassay and ELISA were used to measure ET, TNF, and IL-6 in 35 CHD patients and 20 healthy controls.
  • Plasma ET and serum TNF levels were significantly higher in the CHD group, especially the AMI subgroup, compared to controls (P < 0.01).
  • Serum IL-6 levels showed no significant difference in the narrowed coronary artery group but were significantly elevated in the AMI group (P < 0.01).

Impact:

  • Findings suggest that elevated ET and cytokine levels, particularly TNF and IL-6 in AMI, are strongly associated with the pathogenesis of coronary heart disease.
  • These biomarkers may serve as potential indicators for disease severity and progression in CHD.
  • Further research into the specific mechanisms of ET and cytokine involvement could lead to novel therapeutic strategies for CHD.

Related Concept Videos